info_outline
Tailored Treatment Algorithms, Liquid Biopsy, and Personalized Medicine
09/13/2022
Tailored Treatment Algorithms, Liquid Biopsy, and Personalized Medicine
In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this fifth episode, Joel sits down with Brian Leyland-Jones, MB BS, PhD, CMO, National Foundation for Cancer Research and Peter Kuhn, PhD, Dean’s Professor of Biological Sciences, Professor of Biological Sciences, Medicine, Biomedical Engineering, Aerospace and Mechanical Engineering and Urology, to explore: Historical perspective on personalized approaches to cancer treatment Liquid biopsy as a means to facilitate adaptive treatment regimens tailored to individual cancers Vision of where the field is going and future management paradigms ©2023 Lumanity Inc.
/episode/index/show/8a594302-35b5-46d6-8656-168c5ffffdf8/id/24361572